Verition Fund Management’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-188
Closed -$41K 2643
2022
Q3
$41K Hold
188
﹤0.01% 2710
2022
Q2
$90K Hold
188
﹤0.01% 2093
2022
Q1
$85K Sell
188
-125
-40% -$63.8K ﹤0.01% 2451
2021
Q4
$58K Hold
313
﹤0.01% 2397
2021
Q3
$100K Hold
313
﹤0.01% 1710
2021
Q2
$182K Buy
+313
New +$171K ﹤0.01% 1618

Other funds holding EDVA

Verition Fund Management's EDVA Position: Q4 2022 in Review

Verition Fund Management sold out of Endovia Health Sciences, Inc. (EDVA) in Q4 2022, closing a stake of 188 shares — an estimated $41K sold.

Verition Fund Management first reported a position in EDVA in Q2 2021 and held it in 6 quarters. The position peaked at $182K in Q2 2021. 22 funds tracked by Wall St. Rank hold EDVA as of Q4 2022.

  • Verition Fund Management reported no remaining Endovia Health Sciences, Inc. position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 188 Endovia Health Sciences, Inc. shares in Q4 2022, an estimated $41K.
  • Verition Fund Management first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and held it in 6 quarters.
  • Verition Fund Management's Endovia Health Sciences, Inc. position peaked at $182K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.